Herve Perron - Publications

Affiliations: 
Grenoble 1 

71 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2021 Charvet B, Pierquin J, Brunel J, Gorter R, Quétard C, Horvat B, Amor S, Portoukalian J, Perron H. Human Endogenous Retrovirus Type W Envelope from Multiple Sclerosis Demyelinating Lesions Shows Unique Solubility and Antigenic Characteristics. Virologica Sinica. PMID 33770381 DOI: 10.1007/s12250-021-00372-0  0.34
2020 Kremer D, Weyers V, Gruchot J, Göttle P, Hartung HP, Perron H, Küry P. Meeting report: "Human endogenous retroviruses: HERVs or transposable elements in autoimmune, chronic inflammatory and degenerative diseases or cancer", Lyon, France, november 5th and 6th 2019 - an MS scientist's digest. Multiple Sclerosis and Related Disorders. 42: 102068. PMID 32302965 DOI: 10.1016/J.Msard.2020.102068  0.347
2019 Levet S, Charvet B, Bertin A, Deschaumes A, Perron H, Hober D. Human Endogenous Retroviruses and Type 1 Diabetes Current Diabetes Reports. 19: 141. PMID 31754894 DOI: 10.1007/S11892-019-1256-9  0.346
2019 Kremer D, Perron H, Küry P. Reply to Ruprecht and Mayer: Unearthing genomic fossils in the pathogenesis of multiple sclerosis. Proceedings of the National Academy of Sciences of the United States of America. PMID 31455745 DOI: 10.1073/Pnas.1912315116  0.413
2019 Kremer D, Gruchot J, Weyers V, Oldemeier L, Göttle P, Healy L, Ho Jang J, Kang T Xu Y, Volsko C, Dutta R, Trapp BD, Perron H, Hartung HP, Küry P. pHERV-W envelope protein fuels microglial cell-dependent damage of myelinated axons in multiple sclerosis. Proceedings of the National Academy of Sciences of the United States of America. PMID 31213545 DOI: 10.1073/Pnas.1901283116  0.383
2018 Charvet B, Reynaud JM, Gourru-Lesimple G, Perron H, Marche PN, Horvat B. Induction of Proinflammatory Multiple Sclerosis-Associated Retrovirus Envelope Protein by Human Herpesvirus-6A and CD46 Receptor Engagement. Frontiers in Immunology. 9: 2803. PMID 30574140 DOI: 10.3389/Fimmu.2018.02803  0.384
2018 Göttle P, Förster M, Gruchot J, Kremer D, Hartung HP, Perron H, Küry P. Rescuing the negative impact of human endogenous retrovirus envelope protein on oligodendroglial differentiation and myelination. Glia. PMID 30430656 DOI: 10.1002/Glia.23535  0.326
2018 Curtin F, Bernard C, Levet S, Perron H, Porchet H, Médina J, Malpass S, Lloyd D, Simpson R. A new therapeutic approach for type 1 diabetes: rationale for GNbAC1 an anti-HERV-W-Env monoclonal antibody. Diabetes, Obesity & Metabolism. PMID 29749030 DOI: 10.1111/Dom.13357  0.331
2018 Küry P, Nath A, Créange A, Dolei A, Marche P, Gold J, Giovannoni G, Hartung HP, Perron H. Human Endogenous Retroviruses in Neurological Diseases. Trends in Molecular Medicine. PMID 29551251 DOI: 10.1016/J.Molmed.2018.02.007  0.407
2017 Levet S, Medina J, Joanou J, Demolder A, Queruel N, Réant K, Normand M, Seffals M, Dimier J, Germi R, Piofczyk T, Portoukalian J, Touraine JL, Perron H. An ancestral retroviral protein identified as a therapeutic target in type-1 diabetes. Jci Insight. 2. PMID 28878130 DOI: 10.1172/Jci.Insight.94387  0.394
2017 Kremer D, Glanzman R, Traboulsee A, Nath A, Groc L, Horwitz M, Göttle P, Perron H, Gold J, Hartung HP, Küry P. Prehistoric enemies within: The contribution of human endogenous retroviruses to neurological diseases. Meeting report: "Second International Workshop on Human Endogenous Retroviruses and Disease", Washington DC, March 13th and 14th 2017. Multiple Sclerosis and Related Disorders. 15: 18-23. PMID 28641767 DOI: 10.1016/J.Msard.2017.05.001  0.315
2017 Medina J, Perron H. [DNA sequences from mobile genetic elements, a hidden half of the human genome]. Medecine Sciences : M/S. 33: 151-158. PMID 28240206 DOI: 10.1051/Medsci/20173302010  0.345
2016 van Horssen J, van der Pol S, Nijland P, Amor S, Perron H. Human endogenous retrovirus W in brain lesions: Rationale for targeted therapy in multiple sclerosis. Multiple Sclerosis and Related Disorders. 8: 11-8. PMID 27456869 DOI: 10.1016/J.Msard.2016.04.006  0.445
2016 Faucard R, Madeira A, Gehin N, Authier FJ, Panaite PA, Lesage C, Burgelin I, Bertel M, Bernard C, Curtin F, Lang AB, Steck AJ, Perron H, Kuntzer T, Créange A. Human Endogenous Retrovirus and Neuroinflammation in Chronic Inflammatory Demyelinating Polyradiculoneuropathy. Ebiomedicine. 6: 190-8. PMID 27211560 DOI: 10.1016/J.Ebiom.2016.03.001  0.366
2016 Madeira A, Burgelin I, Perron H, Curtin F, Lang AB, Faucard R. MSRV envelope protein is a potent, endogenous and pathogenic agonist of human toll-like receptor 4: Relevance of GNbAC1 in multiple sclerosis treatment. Journal of Neuroimmunology. 291: 29-38. PMID 26857492 DOI: 10.1016/J.Jneuroim.2015.12.006  0.438
2015 Nath A, Küry P, Sciascia do Olival G, Dolei A, Karlsson H, Groc L, Schneider M, Kriesel J, Touraine JL, Mallet F, Marche PN, Arnaud F, Feschotte C, Perron H. First international workshop on human endogenous retroviruses and diseases, HERVs & disease 2015. Mobile Dna. 6: 20. PMID 30211914 DOI: 10.1186/S13100-015-0051-7  0.303
2015 Curtin F, Perron H, Faucard R, Porchet H, Lang AB. Treatment Against Human Endogenous Retrovirus: A Possible Personalized Medicine Approach for Multiple Sclerosis. Molecular Diagnosis & Therapy. 19: 255-65. PMID 26376649 DOI: 10.1007/S40291-015-0166-Z  0.438
2015 Derfuss T, Curtin F, Guebelin C, Bridel C, Rasenack M, Matthey A, Du Pasquier R, Schluep M, Desmeules J, Lang AB, Perron H, Faucard R, Porchet H, Hartung HP, Kappos L, et al. A phase IIa randomized clinical study testing GNbAC1, a humanized monoclonal antibody against the envelope protein of multiple sclerosis associated endogenous retrovirus in multiple sclerosis patients - a twelve month follow-up. Journal of Neuroimmunology. 285: 68-70. PMID 26198921 DOI: 10.1016/J.Jneuroim.2015.05.019  0.405
2015 Duperray A, Barbe D, Raguenez G, Weksler BB, Romero IA, Couraud PO, Perron H, Marche PN. Inflammatory response of endothelial cells to a human endogenous retrovirus associated with multiple sclerosis is mediated by TLR4. International Immunology. 27: 545-53. PMID 25957268 DOI: 10.1093/Intimm/Dxv025  0.42
2015 Kremer D, Förster M, Schichel T, Göttle P, Hartung HP, Perron H, Küry P. The neutralizing antibody GNbAC1 abrogates HERV-W envelope protein-mediated oligodendroglial maturation blockade. Multiple Sclerosis (Houndmills, Basingstoke, England). 21: 1200-3. PMID 25480862 DOI: 10.1177/1352458514560926  0.385
2015 Curtin F, Perron H, Kromminga A, Porchet H, Lang AB. Preclinical and early clinical development of GNbAC1, a humanized IgG4 monoclonal antibody targeting endogenous retroviral MSRV-Env protein. Mabs. 7: 265-75. PMID 25427053 DOI: 10.4161/19420862.2014.985021  0.426
2015 Derfuss T, Curtin F, Guebelin C, Bridel C, Rasenack M, Matthey A, Du Pasquier R, Schluep M, Desmeules J, Lang AB, Perron H, Faucard R, Porchet H, Hartung HP, Kappos L, et al. A phase IIa randomised clinical study of GNbAC1, a humanised monoclonal antibody against the envelope protein of multiple sclerosis-associated endogenous retrovirus in multiple sclerosis patients. Multiple Sclerosis (Houndmills, Basingstoke, England). 21: 885-93. PMID 25392325 DOI: 10.1177/1352458514554052  0.41
2014 Dolei A, Garson JA, Arru G, Clerici M, Germi R, Marche PN, Perron H. Multiple sclerosis-associated retrovirus and related human endogenous retrovirus-W in patients with multiple sclerosis. Journal of Neuroimmunology. 266: 87-8. PMID 24355750 DOI: 10.1016/J.Jneuroim.2013.11.009  0.336
2013 Perron H, Dougier-Reynaud HL, Lomparski C, Popa I, Firouzi R, Bertrand JB, Marusic S, Portoukalian J, Jouvin-Marche E, Villiers CL, Touraine JL, Marche PN. Human endogenous retrovirus protein activates innate immunity and promotes experimental allergic encephalomyelitis in mice. Plos One. 8: e80128. PMID 24324591 DOI: 10.1371/Journal.Pone.0080128  0.444
2013 Kremer D, Schichel T, Förster M, Tzekova N, Bernard C, van der Valk P, van Horssen J, Hartung HP, Perron H, Küry P. Human endogenous retrovirus type W envelope protein inhibits oligodendroglial precursor cell differentiation. Annals of Neurology. 74: 721-32. PMID 23836485 DOI: 10.1002/Ana.23970  0.333
2013 do Olival GS, Faria TS, Nali LH, de Oliveira AC, Casseb J, Vidal JE, Cavenaghi VB, Tilbery CP, Moraes L, Fink MC, Sumita LM, Perron H, Romano CM. Genomic analysis of ERVWE2 locus in patients with multiple sclerosis: absence of genetic association but potential role of human endogenous retrovirus type W elements in molecular mimicry with myelin antigen. Frontiers in Microbiology. 4: 172. PMID 23805135 DOI: 10.3389/fmicb.2013.00172  0.353
2013 Garcia-Montojo M, Dominguez-Mozo M, Arias-Leal A, Garcia-Martinez Á, De las Heras V, Casanova I, Faucard R, Gehin N, Madeira A, Arroyo R, Curtin F, Alvarez-Lafuente R, Perron H. The DNA copy number of human endogenous retrovirus-W (MSRV-type) is increased in multiple sclerosis patients and is influenced by gender and disease severity. Plos One. 8: e53623. PMID 23308264 DOI: 10.1371/Journal.Pone.0053623  0.411
2012 Perron H, Hamdani N, Faucard R, Lajnef M, Jamain S, Daban-Huard C, Sarrazin S, LeGuen E, Houenou J, Delavest M, Moins-Teisserenc H, Moins-Teiserenc H, Bengoufa D, Yolken R, Madeira A, et al. Molecular characteristics of Human Endogenous Retrovirus type-W in schizophrenia and bipolar disorder. Translational Psychiatry. 2: e201. PMID 23212585 DOI: 10.1038/Tp.2012.125  0.352
2012 Curtin F, Lang AB, Perron H, Laumonier M, Vidal V, Porchet HC, Hartung HP. GNbAC1, a humanized monoclonal antibody against the envelope protein of multiple sclerosis-associated endogenous retrovirus: a first-in-humans randomized clinical study. Clinical Therapeutics. 34: 2268-78. PMID 23200102 DOI: 10.1016/J.Clinthera.2012.11.006  0.406
2012 Perron H, Germi R, Bernard C, Garcia-Montojo M, Deluen C, Farinelli L, Faucard R, Veas F, Stefas I, Fabriek BO, Van-Horssen J, Van-der-Valk P, Gerdil C, Mancuso R, Saresella M, et al. Human endogenous retrovirus type W envelope expression in blood and brain cells provides new insights into multiple sclerosis disease. Multiple Sclerosis (Houndmills, Basingstoke, England). 18: 1721-36. PMID 22457345 DOI: 10.1177/1352458512441381  0.46
2010 Perron H, Lang A. The human endogenous retrovirus link between genes and environment in multiple sclerosis and in multifactorial diseases associating neuroinflammation. Clinical Reviews in Allergy & Immunology. 39: 51-61. PMID 19697163 DOI: 10.1007/S12016-009-8170-X  0.412
2009 Perron H, Bernard C, Bertrand JB, Lang AB, Popa I, Sanhadji K, Portoukalian J. Endogenous retroviral genes, Herpesviruses and gender in Multiple Sclerosis. Journal of the Neurological Sciences. 286: 65-72. PMID 19447411 DOI: 10.1016/J.Jns.2009.04.034  0.479
2009 Saresella M, Rolland A, Marventano I, Cavarretta R, Caputo D, Marche P, Perron H, Clerici M. Multiple sclerosis-associated retroviral agent (MSRV)-stimulated cytokine production in patients with relapsing-remitting multiple sclerosis. Multiple Sclerosis (Houndmills, Basingstoke, England). 15: 443-7. PMID 19251836 DOI: 10.1177/1352458508100840  0.418
2009 Quadrio I, Ugnon-Café S, Dupin M, Esposito G, Streichenberger N, Krolak-Salmon P, Vital A, Pellissier JF, Perret-Liaudet A, Perron H. Rapid diagnosis of human prion disease using streptomycin with tonsil and brain tissues. Laboratory Investigation; a Journal of Technical Methods and Pathology. 89: 406-13. PMID 19188908 DOI: 10.1038/Labinvest.2008.169  0.323
2009 Dolei A, Perron H. The multiple sclerosis-associated retrovirus and its HERV-W endogenous family: a biological interface between virology, genetics, and immunology in human physiology and disease. Journal of Neurovirology. 15: 4-13. PMID 19039700 DOI: 10.1080/13550280802448451  0.362
2009 Bernard C, Veas F, Stefas I, Leboyer M, Perron H. Endogenous retrovirus type W GAG and ENV antigenaemia in serum of schizophrenic patients Retrovirology. 6: 71. DOI: 10.1186/1742-4690-6-S2-P71  0.371
2009 Bernard C, Bertrand J, Stefas I, Veas F, Lang AB, Popa I, Sanhadji K, Mancuso R, Saresella M, Clerici M, Touraine J, Portoukalian J, Perron H. HERV-W envelope is significantly expressed in Multiple Sclerosis and causes neuroinflammation in animal models with specific antibody inhibition Retrovirology. 6: 70. DOI: 10.1186/1742-4690-6-S2-P70  0.474
2008 Perron H, Mekaoui L, Bernard C, Veas F, Stefas I, Leboyer M. Endogenous retrovirus type W GAG and envelope protein antigenemia in serum of schizophrenic patients. Biological Psychiatry. 64: 1019-23. PMID 18760403 DOI: 10.1016/J.Biopsych.2008.06.028  0.356
2008 Leclere E, Moussa A, Chouaf-Lakhdar L, Coleman AW, Seigneurin JM, Perron H, Bencsik A. Prion early kinetics revisited using a streptomycin-based PrP(res) extraction method. Biochemical and Biophysical Research Communications. 372: 429-33. PMID 18489903 DOI: 10.1016/J.Bbrc.2008.05.040  0.603
2008 Bencsik AA, Leclere E, Perron H, Moussa A. New insights into early sequential PrPsc accumulation in scrapie infected mouse brain evidenced by the use of streptomycin sulfate. Histochemistry and Cell Biology. 129: 643-50. PMID 18224331 DOI: 10.1007/S00418-008-0382-2  0.3
2006 Rolland A, Jouvin-Marche E, Viret C, Faure M, Perron H, Marche PN. The envelope protein of a human endogenous retrovirus-W family activates innate immunity through CD14/TLR4 and promotes Th1-like responses. Journal of Immunology (Baltimore, Md. : 1950). 176: 7636-44. PMID 16751411 DOI: 10.4049/Jimmunol.176.12.7636  0.358
2006 Ruprecht K, Obojes K, Wengel V, Gronen F, Kim KS, Perron H, Schneider-Schaulies J, Rieckmann P. Regulation of human endogenous retrovirus W protein expression by herpes simplex virus type 1: implications for multiple sclerosis. Journal of Neurovirology. 12: 65-71. PMID 16595376 DOI: 10.1080/13550280600614973  0.471
2006 Bencsik AA, Coleman AW, Debeer SO, Perron H, Moussa A. Amplified immunohistochemical detection of PrPsc in animal transmissible spongiform encephalopathies using streptomycin. The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society. 54: 849-53. PMID 16549507 DOI: 10.1369/Jhc.5C6895.2006  0.32
2005 Perron H, Lazarini F, Ruprecht K, Péchoux-Longin C, Seilhean D, Sazdovitch V, Créange A, Battail-Poirot N, Sibaï G, Santoro L, Jolivet M, Darlix JL, Rieckmann P, Arzberger T, Hauw JJ, et al. Human endogenous retrovirus (HERV)-W ENV and GAG proteins: physiological expression in human brain and pathophysiological modulation in multiple sclerosis lesions. Journal of Neurovirology. 11: 23-33. PMID 15804956 DOI: 10.1080/13550280590901741  0.429
2005 Garson J, Créange A, Dolei A, Ferrante P, Jouvin-Marche E, Marche PN, Rieger F, Ruprecht K, Saresella M, Sotgiu S, Tedder R, Perron H. MSRV, Syncytin and the role of endogenous retroviral proteins in demyelination. Multiple Sclerosis (Houndmills, Basingstoke, England). 11: 249-50. PMID 15794403 DOI: 10.1191/1352458505Ms1160Xx  0.37
2005 Rolland A, Jouvin-Marche E, Saresella M, Ferrante P, Cavaretta R, Créange A, Marche P, Perron H. Correlation between disease severity and in vitro cytokine production mediated by MSRV (multiple sclerosis associated retroviral element) envelope protein in patients with multiple sclerosis. Journal of Neuroimmunology. 160: 195-203. PMID 15710473 DOI: 10.1016/J.Jneuroim.2004.10.019  0.409
2003 Firouzi R, Rolland A, Michel M, Jouvin-Marche E, Hauw JJ, Malcus-Vocanson C, Lazarini F, Gebuhrer L, Seigneurin JM, Touraine JL, Sanhadji K, Marche PN, Perron H. Multiple sclerosis-associated retrovirus particles cause T lymphocyte-dependent death with brain hemorrhage in humanized SCID mice model. Journal of Neurovirology. 9: 79-93. PMID 12587071 DOI: 10.1080/13550280390173328  0.656
2002 Lafon M, Jouvin-Marche E, Marche PN, Perron H. Human viral superantigens: to be or not to be transactivated? Trends in Immunology. 23: 238-9; author reply . PMID 12102742 DOI: 10.1016/S1471-4906(02)02207-X  0.318
2001 Malcus-Vocanson C, Giraud P, Micoud F, Janin V, Charles MH, Broussolle E, Chazot G, Mandrand B, Perron H. Glial toxicity in urine and multiple sclerosis. Multiple Sclerosis (Houndmills, Basingstoke, England). 7: 383-8. PMID 11795460 DOI: 10.1177/135245850100700607  0.415
2001 Perron H, Jouvin-Marche E, Michel M, Ounanian-Paraz A, Camelo S, Dumon A, Jolivet-Reynaud C, Marcel F, Souillet Y, Borel E, Gebuhrer L, Santoro L, Marcel S, Seigneurin JM, Marche PN, et al. Multiple sclerosis retrovirus particles and recombinant envelope trigger an abnormal immune response in vitro, by inducing polyclonal Vbeta16 T-lymphocyte activation. Virology. 287: 321-32. PMID 11531410 DOI: 10.1006/Viro.2001.1045  0.414
1999 Jolivet-Reynaud C, Perron H, Ferrante P, Becquart L, Dalbon P, Mandrand B. Specificities of multiple sclerosis cerebrospinal fluid and serum antibodies against mimotopes. Clinical Immunology (Orlando, Fla.). 93: 283-93. PMID 10600340 DOI: 10.1006/Clim.1999.4789  0.412
1999 Voisset C, Blancher A, Perron H, Mandrand B, Mallet F, Paranhos-Baccalà G. Phylogeny of a novel family of human endogenous retrovirus sequences, HERV-W, in humans and other primates. Aids Research and Human Retroviruses. 15: 1529-33. PMID 10580403 DOI: 10.1089/088922299309810  0.318
1999 Bouzid M, Buisson M, Morand P, Perron H, Seigneurin J-. Different distribution of H1‐H2 Epstein‐Barr virus variant in oropharyngeal virus and in biopsies of Hodgkin's disease and in nasopharyngeal carcinoma from Algeria. Int. J. Cancer 77, 205–210 (1998) International Journal of Cancer. 80: 485-485. DOI: 10.1002/(Sici)1097-0215(19990129)80:3<485::Aid-Ijc24>3.0.Co;2-S  0.627
1998 Malcus-Vocanson C, Giraud P, Broussolle E, Perron H, Mandrand B, Chazot G. A urinary marker for multiple sclerosis. Lancet (London, England). 351: 1330. PMID 9643801 DOI: 10.1016/S0140-6736(05)79056-5  0.35
1998 Ménard A, Pierig R, Pelletier J, Bensa P, Belliveau J, Mandrand B, Perron H, Rieger F. Detection of a gliotoxic activity in the cerebrospinal fluid from multiple sclerosis patients. Neuroscience Letters. 245: 49-52. PMID 9596353 DOI: 10.1016/S0304-3940(98)00171-2  0.314
1998 Garson JA, Tuke PW, Giraud P, Paranhos-Baccala G, Perron H. Detection of virion-associated MSRV-RNA in serum of patients with multiple sclerosis. Lancet (London, England). 351: 33. PMID 9433428 DOI: 10.1016/S0140-6736(98)24001-3  0.384
1998 Komurian-Pradel F, Paranhos-Baccala G, Bedin F, Paraz A, Voisset C, Ott C, Sodoyer M, Garcia E, Passas D, Mandrand B, Perron H. Molecular identification and characterization of a novel retrovirus (MSRV) isolated from patients with multiple sclerosis (MS) Journal of Neuroimmunology. 90: 75. DOI: 10.1016/S0165-5728(98)91626-5  0.4
1998 Michel M, Malcus-Vocanson C, Jolivet-Reynaud C, Berger I, Mandrand B, Seigneurin J-, Perron H. Characterization of multiple sclerosis associated retro virus expression and its relationship with EBV in B lymphoblastoid cell lines from MS patients Journal of Neuroimmunology. 90: 67. DOI: 10.1016/S0165-5728(98)91582-X  0.395
1998 Jolivet-Reynaud C, Perron H, Generenez L, Dalbon P, Montrant B. Specificities of multiple sclerosis cerebrospinal fluid and serum antibodies against mimotopes Journal of Neuroimmunology. 90: 34. DOI: 10.1016/S0165-5728(98)91384-4  0.312
1998 Garson J, Perron H. Virion-associated MSRV-DNA in multiple sclerosis The Lancet. 351: 755. DOI: 10.1016/S0140-6736(05)78530-5  0.304
1997 Ménard A, Amouri R, Michel M, Marcel F, Brouillet A, Belliveau J, Geny C, Deforges L, Malcus-Vocanson C, Armstrong M, Lyon-Caen O, Mandrand B, Dobránsky T, Rieger F, Perron H. Gliotoxicity, reverse transcriptase activity and retroviral RNA in monocyte/macrophage culture supernatants from patients with multiple sclerosis. Febs Letters. 413: 477-85. PMID 9303559 DOI: 10.1016/S0014-5793(97)00889-2  0.411
1997 Perron H, Garson JA, Bedin F, Beseme F, Paranhos-Baccala G, Komurian-Pradel F, Mallet F, Tuke PW, Voisset C, Blond JL, Lalande B, Seigneurin JM, Mandrand B. Molecular identification of a novel retrovirus repeatedly isolated from patients with multiple sclerosis. The Collaborative Research Group on Multiple Sclerosis. Proceedings of the National Academy of Sciences of the United States of America. 94: 7583-8. PMID 9207135 DOI: 10.1073/Pnas.94.14.7583  0.666
1997 Perron H, Firouzi R, Tuke P, Garson JA, Michel M, Beseme F, Bedin F, Mallet F, Marcel E, Seigneurin JM, Mandrand B. Cell cultures and associated retroviruses in multiple sclerosis. Collaborative Research Group on MS. Acta Neurologica Scandinavica. Supplementum. 169: 22-31. PMID 9174637 DOI: 10.1111/J.1600-0404.1997.Tb08146.X  0.365
1997 Tuke PW, Perron H, Bedin F, Beseme F, Garson JA. Development of a pan-retrovirus detection system for multiple sclerosis studies. Acta Neurologica Scandinavica. Supplementum. 169: 16-21. PMID 9174636 DOI: 10.1111/J.1600-0404.1997.Tb08145.X  0.408
1996 Sarrot-Reynauld F, Perron H, Lalande B, Massot C, Seigneurin J. Prévalence des anticorps dirigés contre un peptide dérivé d'un rétrovirus endogène au cours des maladies systémiques La Revue De MéDecine Interne. 17: 342s. DOI: 10.1016/S0248-8663(97)80873-9  0.564
1995 Rasmussen HB, Geny C, Deforges L, Perron H, Tourtelotte W, Heltberg A, Clausen J. Expression of endogenous retroviruses in blood mononuclear cells and brain tissue from multiple sclerosis patients. Multiple Sclerosis (Houndmills, Basingstoke, England). 1: 82-7. PMID 9345457 DOI: 10.1177/135245859500100205  0.302
1995 Westarp ME, Ferrante P, Perron H, Bartmann P, Kornhuber HH. Sporadic ALS/MND: a global neurodegeneration with retroviral involvement? Journal of the Neurological Sciences. 129: 145-7. PMID 7595609 DOI: 10.1016/0022-510X(95)00087-I  0.373
1993 Perron H, Suh M, Lalande B, Gratacap B, Laurent A, Stoebner P, Seigneurin JM. Herpes simplex virus ICP0 and ICP4 immediate early proteins strongly enhance expression of a retrovirus harboured by a leptomeningeal cell line from a patient with multiple sclerosis. The Journal of General Virology. 74: 65-72. PMID 7678635 DOI: 10.1099/0022-1317-74-1-65  0.365
1992 Perron H, Gratacap B, Lalande B, Genoulaz O, Laurent A, Geny C, Mallaret M, Innocenti P, Schuller E, Stoebner P. In vitro transmission and antigenicity of a retrovirus isolated from a multiple sclerosis patient. Research in Virology. 143: 337-50. PMID 1282730 DOI: 10.1016/S0923-2516(06)80122-6  0.353
1992 Perron H. Biological characterization of a novel retrovirus isolated from patients with multiple sclerosis Journal of Neuroimmunology. 38: 172-173. DOI: 10.1016/0165-5728(92)90115-2  0.365
1991 Perron H, Lalande B, Gratacap B, Laurent A, Genoulaz O, Geny C, Mallaret M, Schuller E, Stoebner P, Seigneurin JM. Isolation of retrovirus from patients with multiple sclerosis. Lancet (London, England). 337: 862-3. PMID 1707471 DOI: 10.1016/0140-6736(91)92579-Q  0.357
Show low-probability matches.